CareRx Corporation

TSX:CRRX.TO

Medical - Care Facilities

Healthcare
$3.21 +0.63%

+$0.02 today

Market cap
$203.06M
Beta
0.62
P/E (TTM)
7.4
EPS (TTM)
$0.43
Dividend yield
1.88%
52W Low $2.70High $4.00

Volume 0.01M

Average 0.04M

CRRX.TO Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

CareRx CorporationTSX: CRRX.TO

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin narrows to 25.4%

Gross margin was 25.4% in Q1 FY2026, down 4.3 pp from a year earlier. On a trailing-twelve-month basis it was 26.5%, down 3.1 pp year over year. Over 3 fiscal years it narrowed by 3.8 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
25.4%-0.2 pp QoQ
Last fiscal yearDec 2025
25.0%-4.4 pp YoY
LTMMar 2026
26.5%-3.1 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-4.3 pp——
1 year-4.4 pp——
3 years-3.8 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
25.0%
Year-over-year change
-4.4pp

Gross Margin vs competitors

How CRRX.TO compares with its peers on the latest reported figures

  • CRRX.TO's LTM Mar 2026 gross margin of 26.5% is the lowest of the 5 companies compared; the peer median is 54.6%.
  • Its year-over-year change of -3.1 pp is the 2nd highest of 5, against a peer median of -13.5 pp.
  • Over three fiscal years its change of -3.8 pp compares with a peer median of -1.3 pp.
CRRX.TO Competitors Peer median
Gross Margin for CRRX.TO and competitors
Company Period LTM level YoY 3-year change
PRN.TOProfound Medical Corp.LTM Mar 202671.0% +4.1 pp+25.6 pp
HLS.TOHLS Therapeutics Inc.LTM Mar 202661.7% -21.3 pp-49.4 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202647.5% -5.8 pp+39.8 pp
DR.TOMedical Facilities CorporationLTM Mar 202644.5% -21.3 pp-28.1 pp
CRRX.TOCareRx CorporationLTM Mar 202626.5% -3.1 pp-3.8 pp
HBP.TOHelix BioPharma Corp.FY2025— ——
Peer median (excluding CRRX.TO) 54.6%-13.5 pp-1.3 pp

Competitors are the stored peer set for CRRX.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue262.63M381.73M370.75M366.71M370.24M
Cost of Revenue187.35M271.79M286.02M258.65M277.61M
Gross Profit75.28M109.93M84.72M108.06M92.63M
Gross Margin28.7%28.8%22.9%29.5%25.0%
Research & Development00000
Selling, General & Admin70.52M102.55M77.5M32.75M34.23M
Operating Expenses70.47M82.24M100.03M103.54M80.75M
Depreciation & Amortization15.39M20.07M19.98M19.19M18.33M
EBITDA9.01M(610K)24.65M23.9M30.22M
EBITDA Margin3.4%-0.2%6.6%6.5%8.2%
Operating Income(3.31M)(21.94M)4.67M4.53M11.88M
Operating Margin-1.3%-5.7%1.3%1.2%3.2%
Interest Income58K278K1.26M63K161K
Interest Expense17.35M15.22M14.27M9.18M6.84M
Other Income / Expenses(20.43M)(13.95M)(14.27M)(8.99M)(8.53M)
Income Before Tax(23.74M)(35.9M)(9.6M)(4.47M)3.35M
Pre-Tax Margin-9.0%-9.4%-2.6%-1.2%0.9%
Income Tax Expense(1.01M)(1.54M)(4.19M)32K(22.77M)
Net Income(22.73M)(34.35M)(5.41M)(4.5M)26.13M
Net Margin-8.7%-9.0%-1.5%-1.2%7.1%
EPS (Basic)(0.65)(0.72)(0.09)(0.07)0.42
EPS (Diluted)(0.65)(0.72)(0.09)(0.07)0.41
Weighted Avg Shares34.86M47.6M57.35M60.25M62.73M
Weighted Avg Shares (Diluted)34.86M47.6M57.35M60.25M64.49M

CareRx Corporation

TSX:CRRX.TO

Intrinsic Alpha fair value

Locked

Current Price

$3.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.